United States
                 Environmental Protection
                 Agency
Office of Health and
Environmental Assessment
Washington DC 20460
                 Research and Development
EPA/600/S8-91/041 July 1991
EPA        Project  Summary
                 Health  Effects Assessment
                 Documents
                   A series of Health Effects Assess-
                 ment (HEA) documents were prepared
                 by the Environmental Criteria and As-
                 sessment Office, Cincinnati, OH, for the
                 Office of Emergency and Remedial Re-
                 sponse.  These documents are brief,
                 summary assessments of potential ad-
                 verse health effects following either oral
                 or inhalation exposure for the purpose
                 of remedial actions.
                   This Project Summary was devel-
                 oped by EPA's Environmental Criteria
                 and Assessment Office, Cincinnati, OH,
                 to announce key findings of the research
                 project that Is fully documented In sepa-
                 rate reports (see Project Report order-
                 Ing Information at back).

                 Introduction
                   These reports summarize and evaluate
                 information relevant to a preliminary in-
                 terim  assessment  of adverse health  ef-
                 fects associated with  specific chemicals
                 and compounds. All estimates of accept-
                 able intakes and carcinogenic potency pre-
                 sented  in this document should  be
                 considered as preliminary and reflect lim-
                 ited  resources  allocated to this  project.
                 Pertinent toxicologic and environmental
                 data were located  through on-line litera-
                 ture searches of the TOXLINE, CANCER-
                 LINE and the CHEMFATE/DATALOG data
                 bases. Secondary sources of  information
                 have also been  relied upon in the prepara-
                 tion of these reports and represent large-
                 scale health assessment efforts that entail
                 extensive peer and Agency review.

                 Discussion
                   The intent in these assessments is to
                 suggest acceptable exposure levels when-
                 ever sufficient data were available. Values
                 were not derived or larger uncertainty fac-
                tors were employed when the variable data
                 were limited in scope tending to generate
                conservative  (i.e., protective)  estimates.
                 Nevertheless, the interim values presented
                 reflect the relative degree of hazard asso-
 ciated  with  exposure or risk  to  the
 chemical(s) addressed.
    Whenever possible, two categories of
 values have been estimated for systemic
 toxicants (toxicants for which cancer is not
 the endpoint of concern). The first, RfDs
 (formerly  AIS—Acceptable Intake Sub-
 chronic) or subchronic reference dose, is
 an estimate of an exposure level that would
 not be expected to cause adverse effects
 when exposure occurs  during a limited
 time interval (i.e., for an interval that does
 not constitute a significant portion of the
 lifespan). This type of exposure estimate
 has not been extensively used, or rigor-
 ously defined, as previous risk assess-
 ment efforts have been primarily directed
 towards exposures from toxicants in ambi-
 ent air or water where lifetime exposure is
 assumed. Animal data used for RfDs esti-
 mates generally  include exposures with
 durations of 30-90 days. Subchronic hu-
 man data are rarely available. Reported
 exposures are usually from chronic occu-
 pational exposure situations or from re-
 ports of acute accidental exposure. These
 values are developed for both  inhalation
 (RfDj,) and oral (RfDgo) exposures.
    The  RfD  (formerly AIC  - Acceptable
 Intake Chronic) is similar in concept and
 addresses chronic exposure. It is an esti-
 mate of an exposure level that would not
 be expected to cause adverse effects when
 exposure occurs for a significant portion of
 the lifespan. The RfD is route-specific and
 estimates  acceptable exposure for either
 oral (RfD0) or inhalation (RfD,) with the
 implicit assumption that exposure by other
 routes is insignificant.
    Composite scores (CSs) for noncar-
 cinogens have also been calculated where
 data permitted. These values are used for
 ranking reportable quantities.
    For compounds for which there is suffi-
 cient evidence of carcinogenicity, RfDs and
 RfD values are not derived.  Since the
 Agency's cancer policy assumes  a pro-
 cess that is not characterized by a thresh-
                                                                     Printed on Recycled Paper

-------
old, any  exposure contributes  an incre-
ment of risk. Consequently, derivation of
these values would be inappropriate. For
carcinogens, q,*s have  been computed
based  on oral and/or inhalation  data if
available. The  q,* represents an upper-
bound estimate on lifetime cancer risk as
estimated by the multi-stage model.
   Inhalation values (RfDg,  RfD, and q,*)
have been developed for purposes of in-
halation exposure evaluations only. These
values do not reflect differential absorption
assumptions appropriate for route-to-route
extrapolation. These estimates have been
developed to be readily transposable to
units of air concentration and have incor-
porated an assumption that exposure con-
centration will be relatively stable across a
24-hour period.
Table 1.      Summary of Risk Assessments
   The primary focus of the brief literature
summaries presented in the HE As is litera-
ture  directly relevant to  hazard  assess-
ment, primarily mammalian toxicologic
evaluations of subchronic or chronic dura-
tion conducted utilizing oral or inhalation
exposure protocols.  The  HEAs generally
reflect secondary sources of information
when available in the form of more exten-
sive agency documentation.

Conclusion
   Table  1 summarizes  the  risk  as-
sessments developed  in  each docu-
ment. IMPORTANT REMINDER! These
assessments were prepared In  1987-
1988 and may have been superseded
by more recent documentation. Please
refer to the following references for the
most current Information.
U.S. EPA Health Effects Assessment
Summary Table. Available from the
National Technical Information Ser-
vice, Springfield, VA, at 703/489-
4807. Order Number PB91-921100.
(This Table is updated quarterly, ev-
ery three months.)
U.S. EPA Integrated Risk Informa-
tion System (IRIS). Available online
from  the   National Library  of
Medicine's Toxicology Data Network
(TOXNET)  and  from the  National
Technical   Information  Service,
Springfield, VA. at 703/489-4807. Or-
der Number PB90-591330. (This data
base is updated quarterly, every three
months.)
Chemical(s) ^Dso
(mg/day)
Acenaphthene
Acenaphthylene
Acetonitrile
Acrolein
Acrylonitrile

Aldrin
Aluminum
Ammonia
Antimony and Compounds
Antimony
ID
ID
4.6
ND
ND

ND
ID
ID
ID

Antimony potassium tartrate
Antimony trioxide
Antimony tetraoxide
Antimony pentoxide
Benzidine

Beryllium and Compounds

Boron and Compounds
Bromomethane
bis(2-chloroethyl)ether
Chloromethane

2-Chlorophenol and
2,4-Dlchtorophenol
Creosote

Dibenzofuran
Dichtorobenzenes
1,2-Dichtorobenzene
1.3-Dichtorobenzene
1.4-Dichtorobenzene
1,2-Dichtoropropane
Dieldrin
Dimethylphenols-2.6-
isomer



ND

ND

6.2
1
ND
ND

0.35
0.2
ID

ID

63
ID
ND
ND
ND
0.42

(mg/day)
ID
ID
0.5
ND
ND

ND
ID
ID

24.5 \ig/day
65.48 ng/day
29.3 \ig/day
30.9\ig/day
32.5\ig/day
ND

ND

6.2
0.1
ND
ND

0.35
0.2
ID

ID

30
ID
ND
ND
ND
0.042

(mg/day)
ID
ID
9.1
ND
ND

ND
ID
7.0
ND





ND

ND

ID
5
ND
ND

ID
ID
ID

ID

31
ID
ND
ND
ND
ID

RfD,
(mg/day)
ID
ID
0.91
ND
ND

ND
ID
7.0
ND





ND

ND

ID
0.5
ND
ND

ID
ID
ID

ID

3.1
ID
ND
ND
ND
ID

CS
ID
ID
21
ND
ND

ND
10
19
ND





ND

ND

21.6
27.9
ND
ND

10.4
11.9
ID

ID

9
ID
ND
ND
ND
21

1,' ,
(mg/kg/dayf
ID
ID
ID
ID
5.4x10'' -oral
0.24-inhal.
17-oral
ID
ID






234.1 3-oral
111-inhal.
4.86-oral
8.4-inhal.
ID
ID
1. 1-oral
1.26x10 ~*-oral
6.32x10 ^-inhal.
ID
ID
11.53-oral
(forBaP)
ID

ID
ID
2.4x1 0~* -oral
6.75x10 *-oral
16
ID

Cancer
Group
D
D
D
C
B1

B2
C
D
D-oral
B2-inhal.




A

B2

D
D
82
C

D
D
B1

D

D
D
B2
B2
B2
D

                                                                                                              Continued

-------
Table 1. Continued
Chemical(s) RfDso
(mg/day)
Dimathylphenols-3,4- 0.98
isomer
2,4-Dinitrotoluena and ND
2,6-Dinitrotoluene ND
1,2-Diphenylhydrazine ND
alpha- and beta- 0.01
Endosulfan
Endrin 0.03
Ethyl Chloride ID
Ethyl Ether 350
Ethylene Dibromide ND

Ethytene Glycol 140
Fluorenes ID
Benzod.kjfluorena ID
Fluorene
Fully Halogenated Methanes
Trichtomfluoromethane 50
(F-11)
Dichloroditiuoromethane 63
(F-12)
Hepiachtor ND
Hexachtoroethane ND
Isophorone ND
Methyl Isobutyl Ketone 35
Mirex ND
Nitrobenzene 0.3
Nitrophenols ID
N-Nitrosodiphenylamine ND
Parathion 0.4
n-Pantane ID
Selected Phthalic Acid Esters
bis(2-ethylhexyl)phthalate ND
Diethyl Phihalate 525
Di-N-Butyl Phthalate 88
Butyl Benzyl Phthalate 111
Di-N-Octyl Phthalate ID
Dimethyl Phthalate
Styrena ND

Tin and Compounds 43.4
Toxaphene ND
1,2,4-Trichlorobenzene 14
2.4.5-Trichlorophenoxy 7
Acetic Acid (2,4,5-T)
Trihalogenated Methanes
Bromotorm 4
Chlorodibromomethane ND
Bromodichloromethana ND
Trimethylbenzenes ID
Vanadium and Compounds
Sodium Metavanadate 1.0
Vanadyl Sulfate 2.0
Vanadium Pentoxide 0.6
Vanadyl Sulfate ID
ID = Insufficient Data
ND = Not Derived (Carcinogen)
NA = NotApplicabla

RfD0
(mg/day)
0.098

ND
ND
ND
0.001

0.02
ID
35
ND

140
ID
ID


20

10

ND
ND
ND
3.5
ND
0.03
ID
ND
0.4
ID

ND
52.5
8.8
11.1
ID

ND

43.4
ND
1.4
2


0.4


ID

0.1
2.0
0.6
1.6




RfDs,
(mg/day)
ID

ID
ID
ND
ID

ID
ID
ID
ND

ID
ID
ID


135.8

33.8

ND
ND
ND
16
ND
0.4
ID
ND
ID
ID

ND
ID
ID
ID
ID

ND

ID
ND
1.75
ID


ID
ID
ID
ID
ID








RfD,
(mg/day)
ID

ID
ID
ND
ID

ID
ID
ID
ND

ID
ID
ID


13.6

3.4

ND
ND
ND
1.6
ND
0.04
ID
ND
ID
ID

ND
ID
ID
ID
ID

ND

ID
ND
0.18
ID


ID
ID
ID
ID
ID








CS
18.5

ND
ND
ND
50

52
ID
10
ND

10
ID
ID


10

7.8

ND
ND
ND
11.5
ND
37.6
ID
ND
36
ID

ND
8
12.8
17
6

ND

28.7
ND
12.4
28


25.8
ND
ND
ID
32.9








(mg/kg/dayr1
ID

0.683

0.768
ID

NA
ID
ID
85-oral
1.37-inhal.
ID
ID
ID


ID

ID

4.5-oral
1.42xW*-oral
4.1x10~3-oral
ID
1.8-oral
ID
ID
4.92x10 ^-oral
ID
ID

8.36x10 ~a-orat
ID
ID
ID
ID

3x10 ''-oral
2.0xW3-inhal.
ID
1.131-oral
ID
ID


ID
8.4x1Q-l!-oral
1.3x10'' -oral
ID
ID








Cancer
Group
D

B2
B2
B2
D

E
D
D
B2

D
C
D


D

D

B2
C
C
D
B2
D
D
B2
C
D

82
D
D
C
D

B2

D
B2
D
D


D
B2
B2
D
D







•&U.S. GOVERNMENT PRINTING OFFICE: IMI - S4H-OZK/4003I

-------
 77)/s Project Summary was prepared by staff of the Environ-
  mental Criteria and Assessment Office, USEPA, Cincinnati,
  OH 45268.
 Deb McKoan is the EPA Project Officer, (see below).
 This Project Summary covers 51 separate reports, entitiled,
  "Updated Health Effects Assessment for..."
 Acenaphthene (Order No. PB88-182068/AS; Cost $15.00)
 Acenaphthylene (Order No. PB88-179510/AS; Cost $15.00)
 Acetonftrile (Order No. PB88-179502/AS; Cost $15.00)
 Acrolein (Order No. PB88-179494/AS; Cost $15.00)
 Acrylonitrile (Order No. PB88-179411/AS; Cost $15.00)
 Aldrin (Order No. PB88-179403/AS; Cost $15.00)
 Aluminum (Order No. PB88-179429/AS; Cost $15.00)
 Ammonia (Order No. PB88-179437/AS; Cost $17.00)
 Antimony and Compounds (Order No. PB88-179445/AS; Cost
  $15.00)
 Benzidine (OrderNo. PB88-179452/AS; Cost $15.00)
 Beryllium and Compounds (Order No. PB88-179460/AS; Cost
  $17.00)
 Boron and Compounds (Order No. PB88-178710/AS; Cost
  $15.00)
 Bromomethane (Order No. PB88-179478/AS; Cost $15.00)
 Bis(2-Chloroethyl)Ether (Order No. PB88-179486/AS; Cost
  $15.00)
 Chtoromethane (Order No. PB88-179932/AS; Cost $15.00)
 2-Chlorophenol and 2,4-Dichlorophenol (Order No. PB88-
   178942/AS; Cost $15.00)
 Creosote (Order No. PB88-179395/AS; Cost $15.00)
 Dibenzofuran (Order No. PB88-179379/AS; Cost $15.00)
 Dichtorobenzenes (Order No. PB88-179387/AS; Cost $17.00)
 1,2-Dichloropropane (Order No. PB88-179940/AS; Cost
  $15.00)
 Dieldrin (Order No. PB88-179957/AS; Cost $17.00)
 Dimethylphenols (Order No. PB88-179965/AS; Cost $15.00)
 2,4- and 2,6-Dinitrotoluene (Order No. PB88-178793/AS; Cost
  $15.00)
 1,2-Diphenylhydrazine (Order No. PB88-180211/AS; Cost
  $15.00)
 Alpha- and Beta-Endosulfan (Order No. PB88-180229/AS;
   Cost $15.00)
 Endrin (Order No. PB88-180237/AS; Cost$15.00)
 Ethyl Chloride (Order No. PB88-182852/AS; Cost $15.00)
            Ethylene Dibromide (Order No. PB88-180245/AS; Cost $17.00)
            Ethylene Glycol (Order No. PB88-180252/AS; Cost $15.00)
            Ethyl Ether (Order No. PB88-180260/AS; Cost $15.00)
            Fluorenes (Order No. PB88-182860/AS; Cost $15.00)
            Fully Habgenated Methanes (Order No. PB88-178728/AS; Cost
              $15.00)
            Heptachbr (Order No. PB88-180278/AS; Cost $15.00)
            Hoxachtoroethane (Order No. PB88-178736/AS; Cost $15.00)
            Isophorone (Order No. PB88-179916/AS; Cost $15.00)
            Methyl Isobutyl Ketone (Order No. PB88-179924/AS; Cost
              $15.00)
            Mirex (Order No. PB88-179908/AS; Cost $15.00)
            NitrobenzenefOrder No. PB88-178975/AS; Cost $15.00)
            Nitrophenols (Order No. PB88-178967/AS; Cost $15.00)
            N-Nitrosodiphenylamine (Order No. PB88-178959/AS; Cost
              $15.00)
            Parathion (OrderNo.  PB88-182878/AS; Cost $15.00)
            n-Pentane (Order No. PB88-179528/AS; Cost $15.00)
            Selected Phthalic Acid Esters (Order No. PB88-178934/AS;
              Cost $17.00)
            Styrene (Order No. PB90-142357/AS; Cost $17.00)
            Tin and  Compounds (Order No. PB88-178926/AS; Cost $15.00)
            Toxaphene (Order No. PB88-182886/AS; Cost $15.00)
            1,2,4-Trichlorobenzene (Order No. PB88-176367/AS; Cost
              $15.00)
            2,4,5-Trichlorophenoxyacetic Acid (Order No. PB90-142365/AS;
              Cost $15.00)
            Trihalogenated Methanes (Order No. PB88-176375/AS; Cost
              $17.00)
            Trimethylbenzenes (Order No. PB88-178801/AS; Cost $15.00)
            Vanadium and Compounds (Order No. PB88-176383/AS; Cost
              $15.00)
                    (All costs are subject to change)

            The above reports will be available only from:
                    National Technical Information Service
                    5285 Port Royal Road
                    Springfield, VA 22161
                    Telephone: 703-487-4650
            The EPA Project Officer can be contacted at:
                    Environmental Criteria and Assessment Office
                    U. S. Environmental Protection Agency
                    Cincinnati, OH 45268
United States
Environmental Protection
Agency
Center lor Environmental Research
Information
Cincinnati, OH 45268
      BULK RATE
POSTAGE & FEES PAID
 EPA PERMIT NO. G-35
Official Business
Penalty for Private Use $300
EPA/600/S8-91/041

-------